FDA 21 CFR Part 11
FDA regulation for trustworthy electronic records and signatures
U.S. SEC Cybersecurity Rules
U.S. SEC regulation for cybersecurity incident disclosures
Quick Verdict
FDA 21 CFR Part 11 ensures electronic records' trustworthiness for life sciences via validation and controls, while SEC Cybersecurity Rules mandate rapid incident disclosure and governance for public firms. Pharma adopts Part 11 for compliance; public companies use SEC rules for investor transparency.
FDA 21 CFR Part 11
21 CFR Part 11 Electronic Records; Electronic Signatures
Key Features
- Criteria for electronic records/signatures equivalent to paper
- Closed system controls including audit trails and access limits
- Open system safeguards with encryption and digital signatures
- Unique electronic signatures linked to records non-repudiable
- Risk-based enforcement discretion per 2003 FDA guidance
U.S. SEC Cybersecurity Rules
Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure
Key Features
- Four-business-day material incident disclosure on Form 8-K
- Annual cybersecurity risk management and governance in Form 10-K
- Inline XBRL tagging for structured, comparable data
- Board oversight and management expertise disclosures
- Inclusion of third-party risks in processes
Detailed Analysis
A comprehensive look at the specific requirements, scope, and impact of each standard.
FDA 21 CFR Part 11 Details
What It Is
FDA 21 CFR Part 11 is a U.S. regulation establishing criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate rule records. The primary approach is control-based with risk-based enforcement discretion outlined in the 2003 FDA guidance.
Key Components
- **Subpart AGeneral provisions, scope, and definitions.
- **Subpart BElectronic records controls for closed (§11.10) and open (§11.30) systems, including validation, audit trails, access limits, and signature linking.
- **Subpart CElectronic signatures requirements for uniqueness, manifestation, and non-repudiation. Core principles include authenticity, integrity, and accountability; no formal certification but FDA inspection enforces compliance.
Why Organizations Use It
Life sciences firms comply to enable paperless operations while meeting predicate rules like CGMP. Benefits include data integrity, inspection readiness, reduced recalls, and efficiency. Mandatory for electronic reliance; mitigates enforcement risks like warning letters.
Implementation Overview
Risk-based: scope records, classify systems (closed/open), validate via CSV (IQ/OQ/PQ), implement controls, train personnel. Applies to pharma, devices, biotech globally if FDA-regulated. Ongoing audits via FDA inspections; no third-party certification.
U.S. SEC Cybersecurity Rules Details
What It Is
U.S. SEC Cybersecurity Rules (Release No. 33-11216) is a federal regulation mandating standardized disclosures for public companies under the Securities Exchange Act. Its primary purpose is enhancing investor protection through timely, comparable cybersecurity information, focusing on material incidents and ongoing risk management for domestic and foreign private issuers.
Key Components
- **Incident disclosureForm 8-K Item 1.05 requires reporting material cybersecurity incidents within four business days of materiality determination.
- **Annual disclosuresRegulation S-K Item 106 covers risk management processes, strategy impacts, board oversight, and management roles.
- **Structured dataInline XBRL tagging for all disclosures. Built on securities-law materiality principles; no fixed controls, emphasizing processes over technical specifics.
Why Organizations Use It
Public companies must comply to avoid enforcement; it improves capital-market efficiency, reduces information asymmetry, and signals strong governance to investors.
Implementation Overview
Phased rollout: incident reporting from Dec 2023 (SRCs June 2024); annual from FYE Dec 2023. Involves cross-functional playbooks, materiality frameworks, board reporting, and XBRL tools. Applies to all Exchange Act registrants; no certification but SEC review/enforcement.
Key Differences
| Aspect | FDA 21 CFR Part 11 | U.S. SEC Cybersecurity Rules |
|---|---|---|
| Scope | Electronic records/signatures trustworthiness in FDA-regulated activities | Cyber incident disclosure and risk governance for public companies |
| Industry | Life sciences, pharma, medical devices (FDA-regulated) | All SEC registrants, public companies, FPIs |
| Nature | Mandatory FDA regulation with enforcement discretion | Mandatory SEC disclosure rule, antifraud enforcement |
| Testing | Risk-based system validation, audit trails, controls testing | Materiality assessments, disclosure controls testing |
| Penalties | Warning letters, seizures, injunctions, fines | Civil penalties, cease-and-desist, officer bars |
Scope
Industry
Nature
Testing
Penalties
Frequently Asked Questions
Common questions about FDA 21 CFR Part 11 and U.S. SEC Cybersecurity Rules
FDA 21 CFR Part 11 FAQ
U.S. SEC Cybersecurity Rules FAQ
You Might also be Interested in These Articles...
Top 5 Reasons TISAX Tabletop Exercises Prevent €10M+ Supply Chain Breaches for ADAS Tier 1 Suppliers in 2025
Unlock top 5 reasons TISAX tabletop exercises deliver 4:1 ROI preventing €10M+ supply chain breaches for ADAS Tier 1 suppliers. ENX case studies & VDA ISA contr
Beyond the Burden: How Intuitive Compliance Software Transforms Daily Workflows
Explore intuitive compliance software that automates workflows, simplifies onboarding, and reduces stress. Cut non-compliance costs 3x and boost efficiency for
CIS Controls v8.1 for Cloud & SaaS: A Practical Safeguard Playbook for AWS/Azure/GCP and Microsoft 365
Turn CIS Controls v8.1 into a cloud-first playbook for AWS, Azure, GCP & Microsoft 365. Get actionable IaaS/PaaS/SaaS safeguards, automation patterns, evidence
Run Maturity Assessments with GRADUM
Transform your compliance journey with our AI-powered assessment platform
Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.
Check out these other Gradum.io Standards Comparison Pages
ISO 31000 vs CIS Controls
Uncover ISO 31000 vs CIS Controls: Enterprise risk guidelines vs cybersecurity safeguards. Align strategy, boost compliance & resilience. Discover differences now!
ISO 50001 vs Basel III
ISO 50001 vs Basel III: Energy mgmt std drives efficiency & savings via EnMS; Basel bolsters bank resilience w/ capital/liquidity rules. Compare impl, audits & ROI now.
NIST 800-171 vs EU AI Act
Compare NIST 800-171 vs EU AI Act: Decode US CUI safeguards & EU high-risk AI rules. Gain insights on controls, compliance gaps & strategies to thrive globally. Read now!